AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

A 2026 paper in The Lancet Healthy Longevity argues that age-related weakness and mobility loss should be understood as problems of the whole motor system, not muscle tissue alone. The authors call for updated diagnostic criteria and research into practical tests and treatments, while acknowledging that the proposed measures have not yet been shown to improve outcomes.

A paper published in The Lancet Healthy Longevity argues that age-related weakness and mobility loss should be understood as problems of the whole motor system, not just declining muscle. The authors say changes in the brain, spinal cord, nerves and their connections with muscle may help explain why strength and everyday function can fall even when muscle loss alone does not account for the decline.

Before you orderOffer from Amazon

Get everyday helpers delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

The paper, by Lucas B. R. Orssatto and colleagues, says the clinical definition of sarcopenia has already moved beyond muscle size. Measures such as grip strength, walking speed and chair stands are used because they predict outcomes including falls, disability and death better than muscle mass does, according to the authors. But they argue that explanations and treatment strategies still tend to center on muscle.

The authors point to evidence that muscle loss explains only a modest share of strength decline in older adults, and that people with similar muscle mass can have different levels of strength and mobility. They also report a mismatch between muscle growth and everyday function: strategies that increase muscle do not necessarily produce comparable gains in what a person can do, while exercise can improve strength and mobility without a measurable change in muscle mass.

Instead, the paper describes aging as affecting the motor system that plans and produces movement. The authors say movement planning may slow, nerve signals may become less reliable or weaker, and balance and position sense may decline. They propose that clinicians continue assessing strength and gait while also considering tasks such as how quickly someone rises from a chair, hand dexterity and walking while talking.

At a glance
reportWhen: Published in The Lancet Healthy Longevi…
The developmentResearchers have published a paper proposing that sarcopenia be reframed as a disease of the aging motor system rather than muscle loss alone.

Why Muscle Size May Not Explain Mobility

The proposed reframing matters because weakness can limit independence even when muscle mass does not fully explain a person’s decline. If the motor system is involved, an assessment focused mainly on muscle may miss other factors affecting movement. The paper’s suggestions could shift attention toward a broader clinical picture, including how movement is controlled and coordinated.

The issue has practical importance in Australia, where falls are a major health burden. The source report cites 253,800 fall-related hospitalizations in 2024–25 and 6,722 deaths following falls in the preceding year. It also reports an estimated A$5.4 billion cost to the health system from fall injuries. The figures describe different time periods and measures; they do not establish that the paper’s proposed approach would prevent falls or reduce costs.

The authors argue that research and care investment should extend beyond interventions focused predominantly on increasing muscle mass. Their proposal could support more targeted strategies for preserving strength, mobility and daily function, but whether broader assessment or treatment will improve patient outcomes remains to be tested.

Products Worth Considering

Jackery Solar Generator 1000 v2 with 200W Solar Panel, 1024Wh LiFePO4 Battery

Jackery Solar Generator 1000 v2 with 200W Solar Panel, 1024Wh LiFePO4 Battery

As an affiliate, we earn on qualifying purchases.

How Sarcopenia Criteria Have Shifted

Sarcopenia describes substantial loss of muscle, strength and physical function associated with aging. The source report says it affects up to 29% of community-dwelling older adults, with higher rates in hospitals, residential elder care and among people with multiple health conditions or frailty. Rates vary by population and setting.

Current assessment already places weight on performance measures such as grip strength, gait speed and chair stands, rather than relying on muscle mass alone. Earlier in 2026, the Australian Journal of General Practice published a proposed algorithm for screening, assessing and managing poor muscle health in primary care, according to the report. The new paper takes the next step by questioning whether the underlying explanation for sarcopenia should also change.

“Reframing sarcopenia as a disease of the ageing motor system”

— Lucas B. R. Orssatto and colleagues, in The Lancet Healthy Longevity

Tests and Benefits Still Unproven

The paper presents a proposed model and research agenda, not proof that motor-system assessments improve care. The authors acknowledge that nobody has yet shown whether the additional measures they suggest outperform existing screening approaches on patient outcomes or cost. Their usefulness in routine primary care, where neuromuscular expertise is not equally available, also remains uncertain.

It is not yet clear which practical tests should be adopted, how well they distinguish different causes of weakness, or whether treatments targeting nerve and muscle function together will preserve mobility more effectively. The reported fall figures establish the scale of the problem, but they do not show that the proposed reframing would reduce falls, hospitalizations or deaths.

Validation Before Clinical Changes

The authors call on international working groups that set sarcopenia diagnostic criteria to consider a five-point research agenda. They want practical assessment measures validated, guidelines to support a staged approach and clinical trials that measure nerve as well as muscle outcomes.

For now, the paper does not establish a replacement diagnostic standard or a new treatment protocol. The next evidence needed is whether the proposed measures can be used reliably in clinical practice and whether using them leads to better function or other outcomes for older adults.

Key Questions

What does the paper propose about sarcopenia?

It proposes understanding sarcopenia as a condition of the aging motor system, which includes the brain, spinal cord, nerves and muscle, rather than as muscle loss alone. This is a research proposal, not a confirmed change to diagnostic standards.

Why might muscle mass alone be an incomplete measure?

The authors say muscle loss explains only a modest share of strength decline, and people with similar muscle mass can have different strength and mobility. They argue that movement control and nerve function also warrant investigation.

What assessments do the authors suggest examining?

Alongside strength and walking speed, they suggest studying the speed of rising from a chair, steadiness during sustained effort, hand dexterity and walking while talking. The paper does not establish that these measures outperform existing screens.

Does the paper show that a new approach prevents falls?

No. The authors call for validation and trials, and say the proposed measures have not been shown to improve outcomes or costs compared with existing screening. The paper does not establish that its approach prevents falls.

Source: medicalxpress.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Why Getting a Second Audiogram Matters

Protect your hearing health by understanding why a second audiogram is essential and how it can reveal important changes you shouldn’t ignore.

Scientists Work to Regrow Inner Ear Hair Cells for Hearing Restoration

Keen scientists are pioneering techniques to regenerate inner ear hair cells, unlocking potential for restoring hearing—discover how these breakthroughs could transform deafness treatments.

Researchers Unveil Sustainable Spirulina Solution To Vitamin B12 Deficiency

Scientists have introduced a new sustainable spirulina-based method to address vitamin B12 deficiency, offering a potential eco-friendly alternative to supplements.

Sanofi investigated by EU over alleged flu vaccine disparagement (SNY:NASDAQ)

The EU has launched an investigation into Sanofi following allegations of disparaging comments about competitors’ flu vaccines.